NCT00008073View on ClinicalTrials.gov

Octreotide and Doxorubicin in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1996

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

doxorubicin hydrochloride

DRUG

octreotide acetate

Trial Locations (1)

15213

University of Pittsburgh Cancer Institute, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT00008073 - Octreotide and Doxorubicin in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter